Dextromethorphan/quinidine for the treatment of bulbar impairment in amyotrophic lateral sclerosis

OBJECTIVE: No efficacious treatments exist to improve or prolong bulbar functions of speech and swallowing in persons with amyotrophic lateral sclerosis (pALS). This study evaluated the short‐term impact of dextromethorphan/quinidine (DMQ) treatment on speech and swallowing function in pALS. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Tabor Gray, Lauren, Locatelli, Eduardo, Vasilopoulos, Terrie, Wymer, James, Plowman, Emily K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424659/
https://www.ncbi.nlm.nih.gov/pubmed/37265174
http://dx.doi.org/10.1002/acn3.51821

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424659/
https://www.ncbi.nlm.nih.gov/pubmed/37265174
http://dx.doi.org/10.1002/acn3.51821

Ejemplares similares